Interpace Biosciences, Inc. (IDXG) stock
IDXGOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/30
$5.00−0.15 (-2.91%)
Close on Oct 19, 2026Market cap $138.57MP/E 5.6Yield –
Interpace Biosciences market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Interpace Biosciences's market cap was $138.50M on Oct 19, 2026, against $4.51M a year earlier. Over the last 2 years it ranged from $3.21M to $209.70M, with a median of $7.88M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $138.50M | +2442.3% |
| 2025 | Dec 31, 2025 | $5.45M | -54.1% |
| 2024 | Dec 31, 2024 | $11.88M | – |
See a number that looks wrong?